You Position: Home > Paper
Molecular pathological epidemiology of hepatocellular carcinoma
( views:21, downloads:0 )
- Author:
- No author available
- Journal Title:
- World Chinese Journal of Digestology
- Issue:
- 9
- DOI:
- 10.11569/wcjd.v26.i9.557
- Key Word:
- 肝癌;分子病理流行病学;分子病理学;分子流行病学;2型糖尿病
Abstract： 分子病理流行病学是在分子病理学和流行病学的基础上发展起来的一门新兴学科,由美国哈佛大学医学院Shuji Ogino教授等在2010年正式提出.肝癌分子病理流行病学研究的是肝癌危险因素、分子标志物和肝癌发生发展及预后三者之间的关系,探索危险因素对肝癌发生发展影响的分子机制,实现对高危人群的分子分型.2型糖尿病已被确认为肝癌的危险因素之一,肝癌分子病理流行病学有助于阐明2型糖尿病对肝癌发生发展影响的分子机制.2017-12-20首届“中日肝癌分子病理流行病学专题研讨会”在北京成功举办.肝癌分子病理流行病学为我们解决肝癌的部分问题提供了机遇和挑战,有助于提升未来肝癌领域的早期预防、分子分型、早期诊断、个体化治疗、预后研究等方面的水平.
- [1].Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma:a cross-sectional case-control study from Chinese patients with HBV infection[J].2013,(4).
- [2]Dongxu, Kang,Zhezhu, Han,Geun Hyeok, Oh,etc.Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib.[J].2017,58(5).
- [3]Kazuyuki Ohata,Keisuke Hamasaki,Kan Toriyama,etc.Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection[J].2003,97(12).
- [4]Somasundaram, Subramaniam,Robin K, Kelley,Alan P, Venook.A review of hepatocellular carcinoma (HCC) staging systems.[J].2013,2(4).
- [5]Brian I. Carr.Hepatocellular carcinoma: Current management and future trends[J].2004,127(Supplement 1).
- [6]H O, Adami,W H, Chow,O, Nyrén,etc.Excess risk of primary liver cancer in patients with diabetes mellitus.[J].1996,88.
- [7]Smith RJ,Malandrino N.Personalized medicine in diabetes.[J].2011,57(2).
- [8]Schuppan D,Afdhal NH.Liver cirrhosis.[J].2008,371(9615).
- [9]Arase,Y.,Kobayashi,M.,Suzuki,F.,etc.Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C[J].2013,57(3).
- [10]Khadija, Rebbani,Agnès, Marchio,Sayeh, Ezzikouri,etc.TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma.[J].2015,14.
- [11]Hui, Tang,Jianwen, Zhang,Zhenyu, Yu,etc.Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.[J].2017,16(6).
- [12]Hashem B. El-serag,Thomas Tran,James E. Everhart.Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma[J].2004,126(2).
- [13]Dyal, Harleen K.,Aguilar, Maria,Bartos, Gabriella,etc.Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review[J].2016,61(2).
- [14]Ichiro Konishi,Yoichi Hiasa,Syuichiro Shigematsu,etc.Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus[J].2009,29(8).
- [15]Carr,B.I..Some new approaches to the management of hepatocellular carcinoma[J].2012,39(4).
- [16]Sizhong, Xing,Bing, Zhang,Ruixi, Hua,etc.URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.[J].2015,15.
- [17]Hui ZHANG,Chun Gao,Long Fang,etc.Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus[J].2013,(15).
- [18]Izzotti, A,Neri, M,Vecchio, D,etc.Molecular epidemiology in cancer research (review)[J].1997,11(5).
- [19]Burkhart, Richard A.,Ronnekleiv-Kelly, Sean M.,Pawlik, Timothy M..Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic response[J].2017,26(2).
- [20]Xiaohua, Duan,Jingquan, Li.Association between MDM2 SNP309, p53 Arg72Pro, and hepatocellular carcinoma risk: A MOOSE-compliant meta-analysis.[J].2017,96(36).
- [21]Menendez, K. R.,Garcia, M.,Spatz, S.,etc.Molecular epidemiology of infectious laryngotracheitis: a review.[J].2014,43(2).
- [22]Ogino, Shuji,Campbell, Peter T.,Nishihara, Reiko,etc.Proceedings of the second international molecular pathological epidemiology (MPE) meeting[J].2015,26(7).
- [23]McCormick F,Harris TJ.The molecular pathology of cancer.[J].2010,7(5).
- [24].Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma[J].2016,(27).